Skip to main content

Want a detailed portfolio tracker?

enGene (ENGN) P/E (2023 - 2026)

enGene (ENGN) P/E from Nov 1, 2023 to Jul 21, 2026. The TTM enGene (ENGN) P/E is -0.88. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of enGene (ENGN)

YearP/EChange
2026-0.88-77.72%
2025-3.95-15.51%
2024-4.68+80.31%
2023-2.60N/A

Comparison enGene (ENGN) P/E with competitors

enGene (ENGN) P/E is -0.88.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.19%
NBYStablecoin Development Corp0.00-100.49%
FGENFibroGen Inc0.24-127.25%
CHRSCoherus Biosciences Inc0.85-196.32%
FBIOFortress Biotech Inc0.95-207.72%
ORMPOramed Pharmaceuticals Inc1.50-270.61%
AGENAgenus Inc3.01-441.62%
INVAInnoviva Inc3.15-458.01%
VXRTVaxart Inc3.55-502.93%
CRMDCorMedix Inc3.63-511.86%
CVACCureVac N.V.4.45-604.63%
GLPGGalapagos NV4.86-651.53%
SRPTSarepta Therapeutics Inc4.88-654.16%
ABEOAbeona Therapeutics Inc5.39-711.53%
ABUSArbutus Biopharma Corp5.60-735.16%
ZVRAZevra Therapeutics Inc5.89-768.26%
SPROSpero Therapeutics Inc6.23-806.99%
CGENCompugen Ltd6.31-816.69%
RIGLRigel Pharmaceuticals6.87-880.05%
SLXNSilexion Therapeutics Corp7.30-928.18%
OMEROmeros Corporation9.26-1150.96%
AUPHAurinia Pharmaceuticals Inc9.58-1187.99%
PLXProtalix BioTherapeutics Inc10.89-1336.24%
ACADAcadia Pharmaceuticals Inc11.73-1431.30%
TBPHTheravance Biopharma Inc12.26-1491.87%
ADMAAdma Biologics Inc12.42-1509.58%
HRMYHarmony Biosciences Holdings Inc13.82-1668.73%
SABSSAB Biotherapeutics Inc14.14-1704.60%
NAGENiagen Bioscience Inc14.82-1782.00%
INCYIncyte Corp15.82-1896.02%
REGNRegeneron Pharmaceuticals Inc15.86-1899.89%
PBYIPuma Biotechnology Inc17.32-2065.51%
CPRXCatalyst Pharmaceuticals Inc17.44-2079.54%
EXELExelixis Inc17.54-2090.74%
TGTXTG Therapeutics Inc18.97-2252.84%
MDXGMimedx Group Inc20.55-2432.92%
XOMAXOMA Royalty Corp22.87-2696.58%
ARGXArgen X SE24.30-2858.14%
CTMXCytomX Therapeutics Inc24.82-2917.52%
XOMAOXOMA Royalty Corp25.34-2976.97%
HALOHalozyme Therapeutics Inc25.62-3008.62%
XOMAPXOMA Royalty Corp25.67-3013.89%
VRTXVertex Pharmaceuticals Inc27.99-3277.77%
RPRXRoyalty Pharma plc - Class A28.69-3356.41%
SLNOSoleno Therapeutics Inc29.02-3393.62%
ASNDAscendis Pharma A/S30.09-3515.10%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4403.51%
APLSApellis Pharmaceuticals Inc39.02-4529.42%
BMRNBiomarin Pharmaceutical Inc42.21-4891.59%
KRYSKrystal Biotech Inc45.34-5247.07%
ONCBeiGene Ltd69.54-7993.75%
PHARPharming Group N.V.75.03-8616.38%
TECHBio-Techne Corp101.96-11673.61%
VCELVericel Corp109.92-12577.51%
ALNYAlnylam Pharmaceuticals Inc117.96-13490.58%
GMABGenmab140.29-16024.84%
TLXTelix Pharmaceuticals Ltd162.15-18506.47%
CORTCorcept Therapeutics Inc212.86-24262.12%